共 30 条
- [21] Effective targeting of KRAS-driven tumors by the first-in-class, orally bioavailable SOS1::KRAS inhibitor BI-3406MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)Hofmann, Marco H.Gmachl, MichaelRamharter, JurgenSavarese, FabioSanderson, Michael P.Gerlach, DanielTrapani, FrancescaBotesteanu, Dana-AdrianaKessler, DirkEttmayer, PeterArnhof, HeribertGerstberger, ThomasSchnitzer, RenateKofink, ChristianeStadtmueller, HeinzWunberg, TobiasO'Connell, Jonathan C.Mendes, Rachel L.Richard, DavidSaldanha, Adrian S.Moll, JuergenPearson, MarkMcConnell, Darryl B.Kraut, Norbert
- [22] Discovery of Novel Coumarin-quinolinium Derivatives as Pan-KRAS Translation Inhibitors by Targeting 5′-UTR RNA G-QuadruplexesJOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (03) : 1961 - 1981Li, Mao-LinDai, Le-TianGao, Zhuo-YuYan, Jia-TongXu, Shu-MinTan, Jia-HengHuang, Zhi-ShuChen, Shuo-BinChen, Xiu-Cai
- [23] Discovery and Characterization of HH100937, a potent and selective SOS1 inhibitor demonstrates synergistic efficacy in combination with KRAS/MAPK therapiesCANCER RESEARCH, 2024, 84 (07)Xie, QingLi, DongshengJiang, ShujuanZhu, JieYu, SongdaYang, MaozhiCai, YaleiLiu, LeiYu, BingTu, WangyangZhang, YixiangLi, Leping
- [24] Discovery of novel diaryl urea-oxindole hybrids as BRAF kinase inhibitors targeting BRAF and KRAS mutant cancersBIOORGANIC CHEMISTRY, 2024, 153Ghannam, Iman A. Y.El Kerdawy, Ahmed M.Mounier, Marwa M.Abo-elfadl, Mahmoud T.Abdel-Mohsen, Heba T.
- [25] HM99462, a novel SOS1 inhibitor, induces tumor regression and synergistic effect with KRAS or EGFR targeted therapy in NSCLCEUROPEAN JOURNAL OF CANCER, 2024, 211 : S36 - S36Park, W.Jung, S. H.Choi, J.Byun, J.Lim, S.Jeon, S.Lee, Y.Ahn, Y. G.
- [26] Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3H)-quinazolinone Aryl Urea pan-RAF Kinase InhibitorJOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (07) : 3940 - 3955Huestis, Malcolm P.Dela Cruz, DarleneDiPasquale, Antonio G.Durk, Matthew R.Eigenbrot, CharlesGibbons, PaulGobbi, AlbertoHunsaker, Thomas L.La, HankLeung, Dennis H.Liu, WendyMalek, ShivaMerchant, MarkMoffat, John G.Muli, Christine S.Orr, Christine J.Parr, Brendan T.Shanahan, FrancesSneeringer, Christopher J.Wang, WeiruYen, IvanaYin, JianpingSiu, MichaelRudolph, Joachim
- [27] Design and Discovery of MRTX0902, a Potent, Selective, Brain- Penetrant, and Orally Bioavailable Inhibitor of the SOS1:KRAS Protein-Protein InteractionJOURNAL OF MEDICINAL CHEMISTRY, 2022, : 9678 - 9690Ketcham, John M.Haling, JacobKhare, ShilpiBowcut, VickieBriere, David M.Burns, Aaron C.Gunn, Robin J.Ivetac, AnthonyKuehler, JonKulyk, SvitlanaLaguer, JadeLawson, J. DavidMoya, KrystalNguyen, NatalieRahbaek, LisaSaechao, BarbaraSmith, Christopher R.Sudhakar, NiranjanThomas, Nicole C.Vegar, LauraVanderpool, DarinWang, XiaolunYan, LarryOlson, PeterChristensen, James G.Marx, Matthew A.
- [28] Evaluation of phosphoprotein- and transcript-based pharmacodynamic biomarkers in pre-linical studies of the novel SOS1::KRAS inhibitor BI-3406MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)Gerlach, DanielSavarese, FabioHofmann, Marco H.Trapani, FrancescaGmachl, MichaelBotesteanu, Dana-AdrianaRamharter, JuergenArnhof, HeribertSchweifer, NorbertMcConnell, Darryl B.Kraut, Norbert
- [29] Effective preclinical treatment of KRAS mutant lung cancers with a combination of MLN0128, an investigational novel mTORC1/2 inhibitor, and a selective MEK inhibitorMOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)Fabrey, RobynAtienza, JoyBriere, DavidBrake, RachaelVincent, Patrick W.
- [30] Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung CancersJOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (14) : 6671 - 6689Lelais, GeraldEpple, RobertMarsilje, Thomas H.Long, Yun O.McNeill, MatthewChen, BeiLu, WenshuoAnumolu, JaganmohanBadiger, SangameshBursulaya, BadryDiDonato, MichaelFong, RinaJuarez, JoseLi, JieManuia, MariMason, Daniel E.Gordon, PerryGroessl, ToddJohnson, KevinJia, YongKasibhatla, ShailajaLi, ChunIsbell, JohnSpraggon, GlenBender, StevenMichellys, Pierre-Yves